75579-3
Comment on fetal 22q11.2 deletion risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Active
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Part Descriptions
LP185989-3 Comment on fetal 22q11.2 deletion risk
22q11.2 deletion syndrome, also known by many other names including DiGeorge syndrome, CATCH22, and velocardiofacial syndrome, is caused by the deletion of a small piece of chromosome 22. 22q11.2 deletion syndrome is associated with variable characteristics including congenital heart disease, recurrent infection due to immune dysfunction, cleft palate and other distinct facial features, cognitive delay and autoimmune disease. The general population risk of 22q11.2 deletion is about 1 in 4,000 live births, and does not change with maternal age. Fetal risk of having 22q11.2 deletion syndrome can be derived from the general population risk as well as prenatal genetic testing of fetal DNA. [MedlinePlus Condition: 22q112-deletion-syndrome]
Source: Regenstrief LOINC, GHR: 22q11.2 deletion syndrome
LP185989-3 Comment on fetal 22q11.2 deletion risk
The genetic counselor's comment regarding risk of a specific disorder or group of disorders is used to convey follow-up recommendations or other information related to the risk result and interpretation.
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Comment on fetal 22q11.2 deletion risk
- Property
- Txt
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Nar
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet 22q11.2 del risk comment
- Display Name
- Comment on fetal 22q11.2 del risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal Comment on fetal 22q11.2 deletion risk
Basic Attributes
- Class
- MOLPATH.DEL
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Release 2.70: COMPONENT: Removed "Genetic counselor" to broaden use since various specialists may provide comments on test results.; Previous Releases: Added "fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Comentario de consejo genético en riesgo de deleción 22q11,2: |
es-MX | Spanish (Mexico) | Comentario del asesor genético sobre el riesgo de deleción fetal 22q11.2: |
fr-FR | French (France) | Risque délétion 22q11.2 foetale (commentaire du conseiller génétique): |
it-IT | Italian (Italy) | Commento su rischio delezione 22q11.2: Synonyms: Delezione genetica DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Testo |
zh-CN | Chinese (China) | 关于胎儿 22q11.2 染色体缺失风险的遗传咨询师意见: Synonyms: WBC.DNA+血浆.cfDNA; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=75579-3
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright